330 related articles for article (PubMed ID: 32791307)
1. Anticoagulation reduces iliocaval and iliofemoral stent thrombosis in patients with cancer stented for nonthrombotic venous obstruction.
Drabkin MJ; Bajwa R; Perez-Johnston R; Bryce Y; Boas FE; Siegelbaum R; Durack JC; Kishore S
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):88-94. PubMed ID: 32791307
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
[TBL] [Abstract][Full Text] [Related]
3. Etiology of iliocaval stent thrombosis.
Aurshina A; Ascher E; Haggerty J; Marks N; Rajaee S; Hingorani A
J Vasc Surg Venous Lymphat Disord; 2020 Mar; 8(2):207-210. PubMed ID: 31843484
[TBL] [Abstract][Full Text] [Related]
4. One-Year Results of Iliocaval Stenting.
Tosenovsky P
Ann Vasc Surg; 2019 Aug; 59():208-216. PubMed ID: 30826434
[TBL] [Abstract][Full Text] [Related]
5. Iliac Vein Stent Placement and the Iliocaval Confluence.
Alsheekh A; Hingorani A; Aurshina A; Kibrik P; Chait J; Ascher E
Ann Vasc Surg; 2020 Feb; 63():307-310. PubMed ID: 31648035
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion.
Attaran RR; Ozdemir D; Lin IH; Mena-Hurtado C; Lansky A
J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):527-534. PubMed ID: 31203859
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes following use of a composite Wallstent-Z stent approach to iliofemoral venous stenting.
Jayaraj A; Noel C; Kuykendall R; Raju S
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):393-400.e2. PubMed ID: 32827734
[TBL] [Abstract][Full Text] [Related]
8. An overview of in-stent restenosis in iliofemoral venous stents.
Saleem T; Raju S
J Vasc Surg Venous Lymphat Disord; 2022 Mar; 10(2):492-503.e2. PubMed ID: 34774813
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center.
Hays K; Jolly M; Silver M; Phillips J; Huff C; Secic M; Ansel G; Kolluri R
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):753-759.e1. PubMed ID: 32827732
[TBL] [Abstract][Full Text] [Related]
10. Lower Extremity Venous Stent Placement: A Large Retrospective Single-Center Analysis.
Mabud TS; Cohn DM; Arendt VA; Jeon GS; An X; Fu J; Souffrant AD; Sailer AM; Shah R; Wang D; Sze DY; Kuo WT; Rubin DL; Hofmann LV
J Vasc Interv Radiol; 2020 Feb; 31(2):251-259.e2. PubMed ID: 31542273
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis.
Avgerinos ED; Saadeddin Z; Abou Ali AN; Pandya Y; Hager E; Singh M; Al-Khoury G; Makaroun MS; Chaer RA
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):153-161. PubMed ID: 30660580
[TBL] [Abstract][Full Text] [Related]
12. Iliocaval Skip Stent Reconstruction Technique for Chronic Bilateral Iliocaval Venous Occlusion.
Barbati ME; Gombert A; Toonder IM; Schleimer K; Kotelis D; de Graaf R; Doganci S; Razavi MK; Jalaie H
J Vasc Interv Radiol; 2020 Dec; 31(12):2060-2065. PubMed ID: 33153863
[TBL] [Abstract][Full Text] [Related]
13. Early thrombosis after iliac stenting for venous outflow occlusion is related to disease severity and type of anticoagulation.
Marston WA; Browder SE; Iles K; Griffith A; McGinigle KL
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1399-1407.e1. PubMed ID: 33667740
[TBL] [Abstract][Full Text] [Related]
14. Routine extended follow-up surveillance of iliac vein stents for iliocaval venous obstruction may not be warranted.
Abdul-Haqq R; Novak Z; Pearce BJ; Matthews TC; Patterson MA; Jordan WD; Passman MA
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):500-505. PubMed ID: 28623984
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting.
Endo M; Jahangiri Y; Horikawa M; Kaufman JA; Schenning RC; Kolbeck KJ; Barton RE; Ohuchi Y; Liang KW; Farsad K
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1691-1698. PubMed ID: 30120531
[TBL] [Abstract][Full Text] [Related]
16. Single-session inferior vena cava filter removal, recanalization, and endovenous reconstruction for chronic iliocaval thrombosis.
Desai KR; Xiao N; Karp J; Salem R; Rodriguez H; Eskandari M; Uddin OM; Lewandowski RJ
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):176-183. PubMed ID: 30612972
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic Iliofemoral and Iliocaval Venous Thrombosis in Patients With Cancer: Endovascular Treatment.
Rabellino M; Moltini P; Di Caro V; García-Mónaco R
Vasc Endovascular Surg; 2018 Nov; 52(8):602-606. PubMed ID: 30079819
[TBL] [Abstract][Full Text] [Related]
18. Novel Approach to Treatment of Chronic Iliocaval Occlusion Utilizing Covered Stents.
Flynn S; Jensen R; Lane J; Bandyk D; Malas M; Barleben A
Ann Vasc Surg; 2020 Aug; 67():300-305. PubMed ID: 32173477
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of stent occlusion after iliocaval stenting.
Jayaraj A; Crim W; Knight A; Raju S
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):56-64. PubMed ID: 30442577
[TBL] [Abstract][Full Text] [Related]
20. Iliofemoral stenting for venous occlusive disease.
Titus JM; Moise MA; Bena J; Lyden SP; Clair DG
J Vasc Surg; 2011 Mar; 53(3):706-12. PubMed ID: 21129907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
